SG110187G - Aqueous suspension of oxendolone - Google Patents

Aqueous suspension of oxendolone

Info

Publication number
SG110187G
SG110187G SG1101/87A SG110187A SG110187G SG 110187 G SG110187 G SG 110187G SG 1101/87 A SG1101/87 A SG 1101/87A SG 110187 A SG110187 A SG 110187A SG 110187 G SG110187 G SG 110187G
Authority
SG
Singapore
Prior art keywords
oxendolone
aqueous suspension
suspension
aqueous
Prior art date
Application number
SG1101/87A
Other languages
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SG110187G publication Critical patent/SG110187G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1101/87A 1981-08-18 1987-12-26 Aqueous suspension of oxendolone SG110187G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56129517A JPS5832899A (ja) 1981-08-18 1981-08-18 オキセンドロン水性懸濁剤

Publications (1)

Publication Number Publication Date
SG110187G true SG110187G (en) 1988-05-20

Family

ID=15011450

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1101/87A SG110187G (en) 1981-08-18 1987-12-26 Aqueous suspension of oxendolone

Country Status (13)

Country Link
US (1) US4462996A (fr)
EP (1) EP0072662B1 (fr)
JP (1) JPS5832899A (fr)
KR (1) KR880001806B1 (fr)
AR (1) AR230730A1 (fr)
CA (1) CA1176983A (fr)
DE (1) DE3263754D1 (fr)
ES (1) ES515057A0 (fr)
GR (1) GR76258B (fr)
HK (1) HK23888A (fr)
MY (1) MY8700654A (fr)
PT (1) PT75435B (fr)
SG (1) SG110187G (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4120311A1 (de) * 1991-06-20 1992-12-24 Kali Chemie Pharma Gmbh Konservierte pharmazeutische zubereitungen
US20050032811A1 (en) * 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
ZA200602347B (en) * 2003-10-23 2007-09-26 Otsuka Pharma Co Ltd Controlled release sterile injectable aripiprazole formulation and method
EP2279727A3 (fr) * 2005-09-15 2011-10-05 Elan Pharma International Limited Formulations nanoparticulaires d'aripiprazole
UA97286C2 (ru) * 2007-07-31 2012-01-25 Оцука Фармасьютикал Ко., Лтд. Способ изготовления суспензии арипипразола и лиофилизированного состава

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861920A (en) * 1954-05-04 1958-11-25 Upjohn Co Therapeutic suspensions of steroids containing pvp and/or pva
US3856829A (en) * 1970-01-07 1974-12-24 Takeda Chemical Industries Ltd 16{62 -hydrocarbon substituted estrane compounds
JPS4832643A (fr) * 1971-09-02 1973-05-01
JPS4966815A (fr) * 1972-10-25 1974-06-28

Also Published As

Publication number Publication date
KR880001806B1 (ko) 1988-09-19
JPS6361957B2 (fr) 1988-11-30
JPS5832899A (ja) 1983-02-25
EP0072662B1 (fr) 1985-05-22
ES8403719A1 (es) 1984-04-01
KR840000901A (ko) 1984-03-26
AR230730A1 (es) 1984-06-29
DE3263754D1 (en) 1985-06-27
CA1176983A (fr) 1984-10-30
EP0072662A2 (fr) 1983-02-23
EP0072662A3 (en) 1983-08-24
HK23888A (en) 1988-04-08
GR76258B (fr) 1984-08-04
MY8700654A (en) 1987-12-31
US4462996A (en) 1984-07-31
PT75435B (pt) 1985-05-31
PT75435A (pt) 1982-09-01
ES515057A0 (es) 1984-04-01

Similar Documents

Publication Publication Date Title
DE3268241D1 (en) Strut type suspension
GB2128558B (en) Construction of suspension arms
JPS54155200A (en) Aqueous suspension of sodium aluminosilicate
DE3564955D1 (en) Aqueous suspensions of solid particles
PL235453A1 (en) Method of manufacture of guanidine derivatives
JPS6460688A (en) Aqueous arylfluorophosphite suspension
PL235333A1 (en) Method of manufacture of guanidine derivatives
GB2099451B (en) Aqueous coal suspension
GB2026006B (en) Aqueous suspension
DE3263754D1 (en) Aqueous suspension of oxendolone
GB2107085B (en) Magnetic suspension
DE3267729D1 (en) Suspension strut assembly
JPS57147977A (en) Monocross suspension structure of autobicycle
ZA823135B (en) Aqueous coal suspension
JPS57147978A (en) Monocross suspension structure of autobicycle
ZA827270B (en) Thiosulfenamide derivatives of n-phosphonomethylglycinonitriles
GB2107309B (en) Preparation of 2-amino-4-hydroxy-5-halo-substituted pyrimidine derivatives
GB2107057B (en) Suspension system
PL239272A1 (en) Method of manufacture of derivatives of guanidine
JPS57147905A (en) Suspension strut assembly
JPS57191397A (en) Dimension stabilizer of paper
GB2090842B (en) Aqueous dispersion
PL239276A1 (en) Method of obtaining guanidine derivatives
JPS57201479A (en) Assembling of suspension door
JPS57191396A (en) Dimension stabilizer of paper